Equities

EMvision Medical Devices Ltd

EMV:ASX

EMvision Medical Devices Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)1.93
  • Today's Change-0.005 / -0.26%
  • Shares traded53.06k
  • 1 Year change+18.40%
  • Beta1.9235
Data delayed at least 20 minutes, as of Nov 18 2024 02:16 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of AUD
(except for per share items)
Fiscal data as of Jun 30 2024202420232022
ASSETS
Cash And Short Term Investments199.976.80
Total Receivables, Net2.9200.07
Total Inventory------
Prepaid expenses0.270.270.20
Other current assets, total0.01----
Total current assets22107.07
Property, plant & equipment, net0.520.800.96
Goodwill, net------
Intangibles, net0.650.480.48
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets24128.51
LIABILITIES
Accounts payable0.290.330.18
Accrued expenses0.370.310.27
Notes payable/short-term debt02.500
Current portion long-term debt/capital leases1.070.230.20
Other current liabilities, total1.682.660.21
Total current liabilities3.416.040.85
Total long term debt1.830.310.54
Total debt2.903.040.74
Deferred income tax0.14----
Minority interest------
Other liabilities, total0.070.050.03
Total liabilities5.466.401.43
SHAREHOLDERS EQUITY
Common stock422623
Additional paid-in capital------
Retained earnings (accumulated deficit)(23)(21)(16)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity195.127.08
Total liabilities & shareholders' equity24128.51
Total common shares outstanding857878
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.